Tagged with ARM

Ireland Ger Brennan, MD (Human Health) of MSD Ireland, highlights his mandate to position MSD for success in an evolving healthcare landscape, the groundbreaking new report on Irish healthcare attitudes and perspectives MSD commissioned, the opportunities and challenges within the Irish market, and MSD’s commitment to putting patients at the center…

Singapore Singapore has pioneered multiple aspects of QuintilesIMS’s global business, and the high profile merger has created interesting opportunities for the organization within the APAC region, beyond strong synergies at the global level. It’s a pleasure to meet with you Anand, as this is the first time PharmaBoardroom has met with…

Philippines Jose Augusto Pascual, President and CEO of PascualLab, sheds light on the company’s current footprint in the Philippines, as well as their ambitions to even further expand their manufacturing capabilities. He also discusses PascualLab’s efforts to be the partner of choice for companies looking to expand into the Philippines. To…

Switzerland How would you present the strengths of the Lake Geneva region’s strengths to our international audience? The Lake Geneva region, which we often call the ‘health valley of Switzerland’, benefits from having two intersecting innovative clusters, one in MedTech and another in biotech. Looking at the course of life sciences…

Ireland Ronan Quinn, CEO of Ardmac, an international provider of high-tech cleanroom facilities to the life sciences sector, tells us the inspiring story of Ardmac’s continued growth through the recent economic recession, the second-generation cleanroom technologies they are bringing to the market, and his positive outlook for Ardmac in the next…

Philippines Cheryl Maley, General Manager of Novartis Philippines, discusses the company’s operations in the country, their growing portfolio of products as well as their impressive focus on research and development in the Philippines. She also discusses some of her key objectives and goals for her first country leadership role. As an…

Mexico Patrick Troop, CEO at Pharma Tycsa, explains the company’s unique business approach in Mexico developing “clinical pharmacies” model to address chronic diseases treatment in the points of care and the importance of public and private partnerships to enhance the national health system. Could you please introduce to our international the…

Luxembourg Despite its miniscule size, Luxembourg has managed to specialize in three key areas and now has a strong claim to be a global leader in personalized healthcare, e-health and data security, and pharma logistics and air freight. “In championing personalized health, the Luxembourg authorities are indicating that they are both…

Pharma 2016 has been a great year for PharmaBoardroom, with interviews from global CEOs and ministers, groundbreaking country reports on some of the world’s key pharma markets, and insightful articles which get to the heart of the sector’s key issues. Stay tuned in 2017 for more of the same! INTERVIEWS OF…

Philippines Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that is driving growth for the branded generics company. As the President of Multicare, could you provide an introduction to Lupin…

Philippines Ivan Alexi Arota, country manager of GE Healthcare Philippines, discusses the company’s extensive efforts to increase access to their innovative, affordable products throughout the country.  He also expands on the important role that partnerships, both with the government and other private companies, play in terms of growing the company as…

Philippines Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based healthcare systems to improve healthcare outcomes. He also discusses how emerging markets are able leverage the fact they have more…